Inflammatory Articular DiseasesNCT06219603
Knowledge and Awareness About Inflammatory Articular Diseases
An observational study of Inflammatory Articular Diseases, run by Syrian Private University at 1 site in Syria.
Trial summary
The manuscript describes the level of knowledge and awareness about Inflammatory Articular Diseases in a Syrian population. we found that awareness of Inflammatory Articular Diseases is mostly bad and very bad in our sample. Read more about this study
- Who is it for?
- Ages 18 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Inflammatory Articular Diseases
- What is being tested?
- survey
- How many people
- 641 participants
- Where
- 1 siteSyria
- Study dates
- 1 Dec 2021to 1 Dec 2022
- How long will I take part?
- 1 Year
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: A random sample from all segments of the Syrian population
Who may be able to join
- all participants older than 18 years and younger than 70
Who cannot join
- Non-Syrians
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Knowledge and Awareness About Inflammatory Articular Diseases: A Cross Sectional Survey From a Syrian Population
The manuscript describes the level of knowledge and awareness about Inflammatory Articular Diseases in a Syrian population. we found that awareness of Inflammatory Articular Diseases is mostly bad and very bad in our sample. Also, we showed how the level of awareness changes due to the change of many factors such as (sex, age, residency, education, marital status, and others ).
Our community-based survey was the first conducted in Syria. we have included a total of 641 participants who were directed to the first part of the survey to complete questions around socio-demographic data and awareness questions about Inflammatory Articular Diseases. We ranked our participants into five levels: excellent, good, average, bad, and very bad.
Finally, we compared our results with other 4 original published studies, and we found many Boolean points of similarity and many other inspiring points of difference.
- Conditions
- Inflammatory Articular Diseases
- Being tested
- survey
- Keywords
- knowledge, Awareness, Inflammatory Articular Diseases, Syrian population
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
surveyOther
questions around socio-demographic information, including age, sex, marital status, residency, education level, and employment status. After that, specific questions were asked to measure the level of knowledge and awareness about rheumatic diseases
| Study group | Role | What they receive |
|---|---|---|
| excellent | participants who answered on > 80 % of the questioned correctly Receives: Other: survey | |
| good | participants who answered on 61 - 80 % of the questioned correctly Receives: Other: survey | |
| average | participants who answered on 41 - 60 % of the questioned correctly Receives: Other: survey | |
| bad | participants who answered on 21 - 40 % of the questioned correctly Receives: Other: survey | |
| very bad | participants who answered on <=20 % of the questioned correctly Receives: Other: survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
knowledge about Inflammatory Articular Diseases
We ranked level of knowledge and awareness about Inflammatory Articular Diseases into five levels: excellent, good, average, bad, and very bad.
higher knowledge level scores mean a better outcome
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jan 2024
- Study start1 Dec 2021
- Primary completion1 Nov 2022
- Study completion1 Dec 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Inflammatory Articular DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 641 participants (actual)
- Target duration
- 1 Year
Sponsor and investigators
- Lead sponsor
- Syrian Private University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Diaa Haj Ali, Syrian Private University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06219603
- Sponsor's protocol ID
- IRB; CW 855.1-12-2021
- Status last verified
- Jun 2024
- First submitted
- 28 Dec 2023
- Last updated
- 10 Jun 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 10 Jun 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Knowledge and Awareness About Inflammatory Articular Diseases: A Cross Sectional Survey From a Syrian Population
- ClinicalTrials.gov ID
- NCT06219603
- Acronym / sponsor ID
- IRB; CW 855.1-12-2021
- Conditions
- Inflammatory Articular Diseases
- Keywords
- knowledge, Awareness, Inflammatory Articular Diseases, Syrian population
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 641 participants (actual)
- Lead sponsor
- Syrian Private UniversityUniversity, hospital or other
- Study start
- 1 Dec 2021 (actual)
- Primary completion
- 1 Nov 2022 (actual)
- Study completion
- 1 Dec 2022 (actual)
- First posted
- 23 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The manuscript describes the level of knowledge and awareness about Inflammatory Articular Diseases in a Syrian population. we found that awareness of Inflammatory Articular Diseases is mostly bad and very bad in our sample. Also, we showed how the level of awareness changes due to the change of many factors such as (sex, age, residency, education, marital status, and others ).
Our community-based survey was the first conducted in Syria. we have included a total of 641 participants who were directed to the first part of the survey to complete questions around socio-demographic data and awareness questions about Inflammatory Articular Diseases. We ranked our participants into five levels: excellent, good, average, bad, and very bad.
Finally, we compared our results with other 4 original published studies, and we found many Boolean points of similarity and many other inspiring points of difference.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Target follow-up
- 1 Year
- Number of arms
- 5
| Arm | Type | Receives |
|---|---|---|
| excellent | – | Other: surveyparticipants who answered on > 80 % of the questioned correctly |
| good | – | Other: surveyparticipants who answered on 61 - 80 % of the questioned correctly |
| average | – | Other: surveyparticipants who answered on 41 - 60 % of the questioned correctly |
| bad | – | Other: surveyparticipants who answered on 21 - 40 % of the questioned correctly |
| very bad | – | Other: surveyparticipants who answered on <=20 % of the questioned correctly |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- A random sample from all segments of the Syrian population
Key inclusion criteria (1 listed)
- all participants older than 18 years and younger than 70
Key exclusion criteria (1 listed)
- Non-Syrians
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| surveyquestions around socio-demographic information, including age, sex, marital status, residency, education level, and employment status. After that, specific questions were asked to measure the level of knowledge and awareness about rheumatic diseases | Other | average, bad, excellent, good, very bad |
Primary outcome
knowledge about Inflammatory Articular Diseases
Time frame: 1 year
We ranked level of knowledge and awareness about Inflammatory Articular Diseases into five levels: excellent, good, average, bad, and very bad. higher knowledge level scores mean a better outcome
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Jun 2024.
- Individual participant dataSharing planned: Undecided
Related trials for Inflammatory Articular Diseases
Not yet recruitingPhase 2
PPV-06 Vaccine in Inflammatory Knee Osteoarthritis
Osteoarthritis, Knee
Active, not recruitingPhase 4
Intraarticular Steroids, Saline and Occupational Therapy in People With CMC1 Osteoarthritis
Osteoarthritis Thumb
RecruitingPhase 1/2
A Study of AZD0120 in Autoimmune Diseases
Systemic Sclerosis, Idiopathic Inflammatory Myopathies
RecruitingPhase 1/2
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Systemic Sclerosis, Idiopathic Inflammatory Myopathies
RecruitingObservational study
Glucocorticoid-induced Osteoporosis in Patients With Chronic Inflammatory Rheumatic Diseases or Psoriasis
Osteoporosis, Inflammatory Rheumatism
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Inflammatory Articular Diseases, run by Syrian Private University at 1 site in Syria.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Syria. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
knowledge about Inflammatory Articular Diseases (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2024.